跳至主要内容
临床试验/NL-OMON42854
NL-OMON42854已完成不适用

A single centre, open label trial investigating the absorption, metabolism and excretion of somapacitan after single subcutaneous dosing in healthy male subjects - Somapacitan 3H-AME study

ovo Nordisk A/S0 个研究点目标入组 7 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • healthy male subjects
  • 45-64 yrs, inclusive
  • BMI: 20.0-29.9 kg/m2, inclusive

排除标准

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 400 mL of blood in the 90 days prior the start of this study.

研究者

相似试验